Zobrazeno 1 - 10
of 32
pro vyhledávání: '"P M Paltuev"'
Autor:
E V Artamonova, V A Gorbunova, N V Zhukov, L V Manzjuk, A G Manihas, P M Paltuev, V F Semiglazov, T Yu Semiglazova, M B Stenina, S A Tjuljandin, V A Chubenko
Publikováno v:
Современная онкология, Vol 16, Iss 2, Pp 12-16 (2014)
The leading oncologists' meeting was held on February 7, 2014 in Moscow. Those in attendance discussed treatment approaches ofbreast cancer, and in particular, locally-advanced and metastatic breast cancer. Participants came to the conclusion that pa
Externí odkaz:
https://doaj.org/article/8d8314f2d766496e8a66aea101011950
Publikováno v:
Современная онкология, Vol 15, Iss 4, Pp 11-12 (2013)
This article deals with the results of a meta-analysis of 12 clinical trials of neoadjuvant therapy in breast cancer. Patients who achievedthe complete morphological regress (marked as урT0урN0 or ут0/isурN0) had improved the survival rate. P
Externí odkaz:
https://doaj.org/article/ef2df74704884af4822b621e4159aa0c
Autor:
R. M. Paltuev, O. A. Volynshchikova, Sh. R. Abdullaeva, S. N. Aleksakhina, A. S. Artemyeva, E. A. Baychorov, S. Yu. Bakharev, Yu. A. Belaya, A. A. Bozhok, V. A. Vasin, V. I. Vladimirov, A. Yu. Vorontsov, E. A. Gaysina, A. A. Gofman, V. N. Dmitriev, E. N. Imyanitov, V. V. Klimenko, A. V. Komyakhov, M. M. Konstantinova, M. V. Kopp, A. G. Kudaybergenova, I. A. Lalak, D. L. Matevosyan, N. M. Mudzhiri, O. V. Poltareva, O. I. Sevryukova, V. F. Semiglazov, T. Yu. Semiglazova, M. M. Urezkova, A. S. Chichkanova, L. A. Churilova, M. V. Shomova
Publikováno v:
Опухоли женской репродуктивной системы, Vol 19, Iss 3, Pp 30-36 (2023)
Background. Individual molecular characteristics of a tumor can serve as a basis for a tailored approach to therapy, prediction of the disease course and outcome, and timely treatment correction in cancer patients. Tumor genomic profiling allows for
Externí odkaz:
https://doaj.org/article/bb685938706842a0aee783498c6077ee
Autor:
V. I. Pavlova, Yu. A. Belaya, A. Yu. Vorontsov, A. A. Prishchepov, S. M. Knyazev, A. A. Mikhaylov, A. V. Kovaleva, E. G. Arevshatyan, R. M. Paltuev, A. V. Chernaya, N. A. Zakharova
Publikováno v:
Опухоли женской репродуктивной системы, Vol 19, Iss 2, Pp 54-60 (2023)
Breast cancer is the most common cancer in women and one of the leading causes of death from cancer in Russia and most countries of the world. In countries with mammographic screening, there is a decrease in mortality from breast cancer. Introduction
Externí odkaz:
https://doaj.org/article/1ebb0bb619c348eeac1dafb59fe2d473
Publikováno v:
Опухоли женской репродуктивной системы, Vol 19, Iss 2, Pp 82-88 (2023)
Background. New biomarkers of breast cancer are actively being studied to used them for breast cancer prognosis and develop optimal approaches to therapy. FOXA1 is one of these factors whose prognostic value for breast cancer has been analyzed in sev
Externí odkaz:
https://doaj.org/article/55d03915007f44d28501147154d0a58a
Publikováno v:
Опухоли женской репродуктивной системы, Vol 19, Iss 2, Pp 89-93 (2023)
Aim. To evaluate the prognostic value of CD4+ in patients with T1–2N0M0 breast cancer.Materials and methods. We performed a quantitative assessment of CD4+ T-lymphocytes in tumor stromal cells and determined the prognostic parameter using the metho
Externí odkaz:
https://doaj.org/article/c745e3a1ae0d4d6aaab5046f0a547b6a
Autor:
R. M. Paltuev, A. G. Kudaybergenova, V. F. Semiglazov, A. S. Artemyeva, T. Yu. Semiglazova, A. V. Komyakhov, O. A. Volynshchikova, V. V. Klimenko, M. M. Urezkova
Publikováno v:
Опухоли женской репродуктивной системы, Vol 19, Iss 1, Pp 56-68 (2023)
Aim. To increase the efficacy of systemic breast cancer therapy and reduce inappropriate prescriptions using individual immunohistochemical tumor characteristics, as well as to develop prognostic scales to ensure a tailored approach to adjuvant syste
Externí odkaz:
https://doaj.org/article/0912cd61a86340dd8c2b80d35f9f8d94
Autor:
M. M. Konstantinova, R. M. Paltuev
Publikováno v:
Опухоли женской репродуктивной системы, Vol 19, Iss 1, Pp 90-98 (2023)
Many patients with different malignancies require analgesic therapy not only at advanced stages of the disease, but also during their diagnosis and treatment, as well as after treatment completion to ensure pain relief. New highly effective painkille
Externí odkaz:
https://doaj.org/article/1c5a317c31754a5aa83b2b02c4cde846
Autor:
R. M. Paltuev, S. N. Aleksakhina, A. S. Artemyeva, E. A. Baychorov, S. Yu. Bakharev, A. A. Bozhok, V. A. Vasin, V. I. Vladimirov, O. A. Volynshchikova, A. Yu. Vorontsov, E. A. Gaysina, A. A. Hoffman, E. N. Imyanitov, V. V. Klimenko, A. V. Komyakhov, M. M. Konstantinovа, M. V. Kopp, A. G. Kudaybergenova, I. A. Lalak, D. L. Matevosyan, N. M. Mudzhiri, O. V. Poltareva, O. I. Sevryukova, V. F. Semiglazov, T. Yu. Semiglazova, M. M. Urezkova, L. A. Churilova
Publikováno v:
Опухоли женской репродуктивной системы, Vol 19, Iss 1, Pp 69-81 (2023)
Background. Breast cancer is one of the most common female malignancies. Molecular diagnostic methods of tumor profiling allow us to analyze individual tumor characteristics, identify new prognostic and predictive markers. Aim. To increase the effica
Externí odkaz:
https://doaj.org/article/cc538d9ba3a84480917cd97d5f495115
Autor:
D. A. Enaldieva, P. V. Krivorotko, E. N. Imyanitov, E. K. Zhiltsova, R. V. Donskikh, A. P. Sokolenko, L. F. Shaykhelislamova, T. T. Tabagua, L. P. Gigolaeva, A. V. Komyakhov, K. S. Nikolaev, K. Yu. Zernov, S. S. Ereshchenko, R. M. Paltuev, A. A. Bessonov, A. S. Artemyeva, R. S. Pesotskiy, N. S. Amirov, A. S. Emelyanov, V. V. Mortada, Ya. I. Bondarchuk, V. V. Semiglazov, T. Yu. Semiglazova, V. F. Semiglazov, A. M. Belyaev
Publikováno v:
Опухоли женской репродуктивной системы, Vol 19, Iss 1, Pp 48-55 (2023)
Background. BRCA-associated triple negative breast cancer (TNBC) is considered one of the most aggressive subtypes of breast cancer with high sensitivity to chemotherapy, which leads to increased interest in finding new treatment options for patients
Externí odkaz:
https://doaj.org/article/f7969acdde894223bd4331d72b66866d